Provectus Biopharmaceuticals Balance Sheet (2010-2026)

Reported Financials

Provectus Biopharmaceuticals Quarterly Balance Sheet

Periods 64 quarters

Latest Jun 2026

Provectus Biopharmaceuticals reported total assets of $1.47M and total liabilities of $7.76M for the quarter ended Jun 2026, up 121.2% year over year. This balance sheet covers 64 quarters of results from Jun 2010 through Jun 2026, standardized by Business Quant from the company’s SEC filings.

Balance SheetBalance Sheet	Jun2021	Sep2021	Dec2021	Mar2022	Jun2022	Sep2022	Dec2022	Mar2023	Jun2023	Sep2023	Dec2023	Mar2024	Jun2024	Sep2024	Dec2024	Mar2025	Jun2025	Sep2025	Dec2025	Jun2026
Assets
Current Assets
Cash & EquivalentsCash & Equiv.	0.05M	0.25M	3.11M	2.48M	2.03M	1.71M	1.43M	1.32M	1.36M	1.41M	1.03M	0.76M	0.59M	0.61M	0.49M	0.47M	0.42M	0.07M	0.25M	1.16M
Cash & Current Investments	0.05M	0.25M	3.11M	2.48M	2.03M	1.71M	1.43M	1.32M	1.36M	1.41M	1.03M	0.76M	0.59M	0.61M	0.49M	0.47M	0.42M	0.07M	0.25M	1.16M
Receivables - NetNet Receivables	0.01M	0.00M	0.01M	0.00M	0.00M	564.00	394.00	767.00	0.00M	947.00	476.00	98.00	767.00
Receivables - OtherOther Receivables	0.01M	0.00M	2.86M	2.23M	1.78M	1.46M	1.18M	1.07M	1.11M	1.16M	0.78M	0.51M	0.34M	0.36M	0.24M	0.22M	0.17M		0.00M
Receivables	0.01M	0.00M	2.86M	2.23M	1.79M	1.46M	1.18M	1.07M	1.11M	1.16M	0.78M	0.51M	0.34M
Prepaid Assets	0.29M	0.25M	0.33M	0.23M	0.24M	0.19M	0.47M	0.27M	0.21M	0.18M	0.34M	0.25M	0.21M	0.15M	0.49M	0.18M	0.15M	0.21M	0.32M	0.21M
Current Assets	0.35M	0.51M	3.44M	2.71M	2.28M	1.90M	1.90M	1.60M	1.58M	1.59M	1.36M	1.01M	0.80M	0.76M	0.98M	0.65M	0.57M	0.28M	0.57M	1.37M
Non-Current Assets
Property, Plant & Equipment (Net)PP&E (Net)	0.04M	0.04M	0.03M	0.03M	0.03M	0.02M	0.02M	0.02M	0.02M	0.01M	0.01M	0.01M	0.01M	0.01M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M
Intangibles
Goodwill & Intangibles
Other Non-Current Assets			2.42M	2.31M	1.95M	1.64M	1.41M	1.29M	1.18M	1.04M	0.95M	0.74M	0.56M	0.43M	0.18M	0.08M	0.03M
Non-Current Assets	0.12M	0.09M	0.07M	0.04M	0.16M	0.15M	0.14M	0.12M	0.11M	0.10M	0.08M	0.07M	0.06M	0.04M	0.03M	0.02M	0.15M	0.14M	0.13M	0.10M
Assets	0.47M	0.60M	3.51M	2.76M	2.44M	2.05M	2.04M	1.72M	1.69M	1.69M	1.45M	1.08M	0.86M	0.80M	1.01M	0.67M	0.72M	0.42M	0.70M	1.47M
Liabilities
Current Liabilities
Accounts Payables	1.21M	1.26M	1.29M	1.60M	1.89M	1.94M	2.09M	1.91M	1.99M	1.79M	1.68M	1.37M	1.32M	1.38M	1.11M	2.96M	3.98M	4.05M	0.72M	4.14M
Notes Payables		0.20M	1.26M	1.31M	1.81M	1.81M	0.63M	0.58M	0.15M	0.78M	0.28M	0.19M	0.11M	0.11M	0.21M	0.12M	0.05M	0.11M	0.22M	0.09M
Payables	1.21M	1.46M	2.55M	2.91M	3.70M	3.75M	2.72M	2.48M	2.14M	2.56M	1.95M	1.56M	1.43M	1.49M	1.31M	3.09M	4.04M	4.16M	0.93M	4.23M
Accumulated Expenses			0.01M	0.04M	0.07M	0.10M	0.03M	0.04M	0.00M	0.01M	0.02M	0.15M	0.15M	0.13M	0.17M	0.15M	0.15M	0.14M	0.14M	0.16M
Other Accumulated Expenses	1.65M	1.81M	2.00M	2.19M	2.33M	2.44M	2.40M	2.76M	2.88M	3.06M	3.24M	3.10M	3.39M	1.56M	2.18M	2.20M	2.62M	2.82M	3.16M	3.16M
Current Deferred Revenue			2.50M	2.31M	1.99M	1.68M	1.51M	1.31M	1.14M	1.07M	0.95M	0.72M	0.46M	0.35M	0.34M	0.06M
Total Current Liabilities	3.08M	3.55M	7.70M	7.82M	8.49M	8.82M	8.19M	8.66M	8.93M	9.17M	9.02M	8.52M	8.37M	6.22M	6.98M	5.74M	6.49M	6.47M	6.90M	7.71M
Non-Current Liabilities
Non-Current Debt	0.13M	0.07M	0.24M	0.15M	0.14M	0.07M	0.24M	0.16M	0.15M	0.08M	0.28M	0.19M	0.11M	0.11M	0.21M	0.12M	0.05M	0.15M	0.24M	0.09M
Convertible Debt			1.46M				1.83M	2.38M	2.60M	2.99M	2.68M	2.94M	2.89M	2.65M					0.10M	3.47M
Minority Interest															-0.01M	0.03M	0.00M	-0.02M	0.00M	-0.01M
Operating Leases					0.10M	0.09M	0.07M	0.06M	0.05M	0.04M	0.03M	0.01M					0.10M	0.09M	0.08M	0.05M
Other Non-Current Liabilities
Total Non-Current Liabilities
Total Liabilities	3.08M	3.55M	7.70M	7.82M	8.59M	8.91M	8.27M	8.72M	8.98M	9.21M	9.04M	8.53M	8.37M	6.22M	6.98M	5.74M	6.60M	6.59M	7.00M	7.76M
Shareholder's Equity
Total Debt	0.13M	0.27M	1.50M	1.46M	1.95M	1.88M	0.86M	0.73M	0.15M	0.85M	0.28M	0.19M	0.11M	0.11M	0.21M	0.12M	0.05M	0.26M	0.46M	0.09M
Common Equity	-2.61M	-2.95M	-4.19M	-5.07M	-6.15M	-6.86M	-6.23M	-7.00M	-7.30M	-7.52M	-7.59M	-7.45M	-7.51M	-5.42M	-5.97M	-5.07M	-5.87M	-6.17M	-6.30M	-6.29M
Liabilities and Shareholders Equity	0.47M	0.60M	3.51M	2.76M	2.44M	2.05M	2.04M	1.72M	1.69M	1.69M	1.45M	1.08M	0.86M	0.80M	1.01M	0.67M	0.72M	0.42M	0.70M	1.47M
Retained Earnings	-243.74M	-244.80M	-246.03M	-247.06M	-248.14M	-248.86M	-249.59M	-250.42M	-251.25M	-252.03M	-252.69M	-253.19M	-254.04M	-255.06M	-257.42M	-258.56M	-260.38M	-261.69M	-262.85M	-265.13M
Preferred Shares	0.02M	0.02M	0.02M	0.02M	0.02M	0.02M	0.02M	0.02M	0.02M	0.02M	0.02M	0.02M	0.01M	0.01M	0.01M	0.01M	0.01M	0.01M	0.02M	0.02M

Provectus Biopharmaceuticals Balance Sheet API

Pull Provectus Biopharmaceuticals's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/statements?ticker=PVCT&statement=BS&frequency=Quarter&period=all&api_key=YOUR_API_KEY

import requests

url = "https://data.businessquant.com/statements"
params = {"ticker": "PVCT", "statement": "BS", "frequency": "Quarter", "period": "all", "api_key": "YOUR_API_KEY"}

data = requests.get(url, params=params).json()

const res = await fetch("https://data.businessquant.com/statements?ticker=PVCT&statement=BS&frequency=Quarter&period=all&api_key=YOUR_API_KEY");
const data = await res.json();

API documentation

Provectus Biopharmaceuticals PVCT Balance Sheet (2010-2026)

Provectus Biopharmaceuticals Quarterly Balance Sheet

Provectus Biopharmaceuticals Balance Sheet API

Create an account

Sign In

Reset Password